Cart
sales@molnova.com
Nomifensine (maleate)
CAS No. 32795-47-4
Nomifensine (maleate)( (±)-Nomifensine maleat )
Catalog No. M22410 CAS No. 32795-47-4
Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 33 | In Stock |
|
| 25MG | 53 | In Stock |
|
| 50MG | 78 | In Stock |
|
| 100MG | 141 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNomifensine (maleate)
-
NoteResearch use only, not for human use.
-
Brief DescriptionNomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
-
DescriptionNomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
-
In Vitro——
-
In Vivo——
-
Synonyms(±)-Nomifensine maleat
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
Recptordopamine uptake
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number32795-47-4
-
Formula Weight354.4
-
Molecular FormulaC20H22N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:80 mg/mL (225.73 mM); H2O:2.2 mg/mL (6.21 mM; Need ultrasonic)
-
SMILESOC(=O)\C=C/C(O)=O.CN1CC(c2ccccc2)c2cccc(N)c2C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kinney J L . Nomifensine maleate: a new second-generation antidepressant.[J]. Clinical Pharmacy, 1985, 4(6):625-636.
molnova catalog
related products
-
PF-592379
A potent, selective, orally active agonist of dopamine D3 receptor with EC50 of 21 nM; displays >470 and 180-fold functional selectivity over D2 and D4 dopamine receptors, respectively.
-
SPD-473 citrate
SPD-473 citrate (BTS 74398 citrate) is a dopamine reuptake inhibitor, a norepinephrine transporter protein (NET) inhibitor.
-
DOPEXAMINE
Dopexamine is a dopaminergic agonistDopexamine hydrochloride has interesting vasodilator properties, with marked intrinsic agonist activity at beta-2 adrenoreceptors and a lesser agonist activity at dopaminergic receptors (DA1 and DA2).?
